Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2010
06/23/2010CN101104857B Cytochrome P450 enzyme and NADPH-cytochrome P450 oxidation-reduction enzyme of crab-eating macaque
06/23/2010CN101003569B Antigen epitope and mutant of lyase in gamma bacteriophage of anthrax bacillus, and application
06/23/2010CN101001958B Improved transformation of soybean
06/22/2010US7741548 unique fusion gene expressing isopentenyl transferase (IPT) that increases endogenous cytokinin production, useful for transforming plants, resulting in alteration of the plant phenotype with respect to shoot and floral tissue response, but not affecting root growth or function
06/22/2010US7741547 Plants and seeds of hybrid corn variety CH569005
06/22/2010US7741546 Plants and seeds of corn variety CV695186
06/22/2010US7741544 Inbred corn line G07-NPIC3426
06/22/2010US7741543 Cotton variety 03H070
06/22/2010US7741542 Canola oil having increased oleic acid and decreased linolenic acid content
06/22/2010US7741541 Method for obtaining improved fertility restorer lines for transgenic male sterile crop plants and a DNA construct for use in said method
06/22/2010US7741540 for selective fertilization of a transgenic plant comprising a polypeptide that metabolizes a D-amino acid substrate; selective herbicide composition with a D-amino acid; detoxification of phytotoxic D-amino acids such as D-alanine and D-serine; able to utilise that D-amino acid as a nitrogen source
06/22/2010US7741539 efficient method for producing glycosylated proteins comprising animal glycosylation patterns comprising sialic acid residues; producing sialic acid or CMP-sialic acid in a transformed non-mammalian eukaryotic cell, tissue or organism
06/22/2010US7741538 gene silencing is avoided by use of monocot-homeologous sequences from plants of the genus Coix for transformation; isolated DNA molecule that exhibits terminator activity comprising a nucleic acid sequence
06/22/2010US7741537 S-adenosyl-L-methionine synthetase promoter and its use in expression of transgenic genes in plants
06/22/2010US7741536 Stable plastid transformation and expression vector for transferring target nucleotide sequences into plants for mass production of affordable vaccines and pharmaceutical agents
06/22/2010US7741535 Isolated polynucleotide comprising a nucleotide sequence encoding a polypeptide having Uridine 5'-diphosoph-glucose 4-Epimerase activity; result in grains with reduced cell-wall constituents (fiber) and increased levels of starch
06/22/2010US7741534 Cytokinin oxidase promoter from maize
06/22/2010US7741533 Grain quality through altered expression of seed proteins
06/22/2010US7741532 Diacylglycerol acyl transferase proteins
06/22/2010US7741531 Method for modifying gene expression of a phytopathogenic fungus
06/22/2010US7741530 Multi-gene expression constructs containing modified inteins
06/22/2010US7741529 mice which comprise a mutation in the gene encoding for the cardiac ryanodine receptor (RyR2); used in drug screening and for understanding the molecular basis of RyR2 dependent arrhythmias
06/22/2010US7741470 siRNA targeting gremlin
06/22/2010US7741469 using small nucleic acid molecules to modulate the expression of genes encoding proteins involved in deafness caused by dominant negative mechanism of action
06/22/2010US7741468 protein hLRTM4 and the polynucleotide which encodes it; used to treat liver injury, hepatocellular carcinoma
06/22/2010US7741466 Cellulase for use in conversion of cellulosic feedstocks into ethanol; recombinant host cell
06/22/2010US7741465 Chimeric receptor genes and cells transformed therewith
06/22/2010US7741460 Generation of transgenic microorganism coding enzymatic polypeptide with enhanced capabilities associated with lysine biosynthesis; improving animal feeds, cosmetics and pharmeceutical agents
06/22/2010US7741458 Spinocerebellar ataxia type 8 and methods of detection
06/22/2010US7741456 Polyketides and antibiotics produced by combinatorial techniques
06/22/2010US7741452 produced by introducing amino acid mutation(s) so that no glycosylation take place at at least one glycosylation site of hepatocyte growth factor; more stable in the blood circulation
06/22/2010US7741451 Antibodies that specifically bind hedgehog-derived polypeptides
06/22/2010US7741447 Antibody against tumor specific antigen as target
06/22/2010US7741445 Multidrug resistance proteins; xenobiotic transporters; counteracting the mechanism of drug resistance so to provide a longer and more effective course of chemotherapeutic drug treatment for cancer patients
06/22/2010US7741444 Neoplasm specific antibodies and uses thereof
06/22/2010US7741440 Apoptin-associating protein
06/22/2010US7741439 Isolated stra6 polypeptides
06/22/2010US7741438 used in reducing bitterness by cleaving bitter peptides; for cheesemaking; treatment or prevention of celiac sprue or as a food additive
06/22/2010US7741434 High-affinity antagonists of ELR-CXC chemokines
06/22/2010US7741308 DBAIT and uses thereof
06/22/2010US7741307 Oligonucleotide sequences which bind biomolecules such as peptides, hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals; selectively bind coagulation factors, E2F family members, Ang1 or Ang2
06/22/2010US7741306 increasing the sensitivity of a cell or tissues to cytotoxic cancer therapy with a naturally occurring nucleic acids
06/22/2010US7741305 antisense therapy; for diagnosis and treatment of atherosclerosis, hypercholesterolemia, or coronary artery disease
06/22/2010US7741303 Stimulation of cellular regeneration and differentiation in the inner ear
06/22/2010US7741302 cis-element of Oryzias Latipes Tol2 element (inverted terminal repeat sequences); plasmids
06/22/2010US7741301 Transposase and method of gene modification
06/22/2010US7741300 Methods of using nucleic acid vector-lipid complexes
06/22/2010US7741299 pulmonary disorders, microvascular disorders, eye diseases (glaucoma) and respiratory conditions
06/22/2010US7741297 Cpg sites; point mutations; immunogens; cancer
06/22/2010US7741284 BMP10 propeptides and related methods
06/22/2010US7741282 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein
06/22/2010US7741279 Modified pro-alpha chain of at least part of a secretory leukocyte protease inhibitor that is placed N-terminal to a triple helical forming domain of the pro-alpha chain; procollagen molecule; collagen matrix; treating chronic wounds and fibrotic disorders
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7741272 Inhibiting angiogenesis in a mammal by administering Eph receptor antagonist ; cardiovascular disorders
06/22/2010US7741271 atopic diseases such as allergies, asthma, eosinophilia, glomerulonephritis; hyperplastic conditions such as cancer; T cell immunologobulin and mucin domain (TIM)
06/22/2010US7741270 Luminescent markers
06/22/2010US7741119 Zymomonas with genetic modification to the glucose-fructose oxidoreductase gene resulting in reduced expression of GFOR enzyme activity; exhibits reduced production of xylitol, a detrimental by-product of xylose metabolism; consumes more xylose and produces more ethanol during mixed sugar fermentation
06/22/2010US7741118 Modifying a wild-type structural gene sequence encoding an insecticidal protein of Bacillus thuringiensis to enhance the expression of protein in plants by removing polyadenylation signals and retaining a sequence which codes such protein
06/22/2010US7741115 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells
06/22/2010US7741113 Cell-specific molecule and method for importing DNA into osteoblast nuclei
06/22/2010US7741112 nucleic acid comprising a sequence encoding a mitochondrial localization signal from subunit VIII of human cytochrome oxidase operably linked to a sequence encoding a viral receptor
06/22/2010US7741111 CaM multi-functional protein kinase; for systematic study of the role of protein kinases in mammary gland development and carcinogenesis
06/22/2010US7741110 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
06/22/2010US7741101 converting 5'-xanthylic acid (XMP) to 5'-guanylic acid (GMP); accumulating GMP synthetase in a high concentration in a culture medium using the microbial strain
06/22/2010US7741100 Method for highly expressing recombinant glucose dehydrogenase derived from filamentous fungi
06/22/2010US7741098 Plasmid vector for expression in caenorhabditis elegans and in escherichia coli; heterologous gene expression
06/22/2010US7741095 Serine protease for enhancing washing performance of detergents; laundry and dishwashing; isolated from Bacillus strains
06/22/2010US7741090 Glucose dehydrogenase and process for producing the dehydrogenase
06/22/2010US7741089 Laccases, nucleic acids encoding them and methods for making and using them
06/22/2010US7741087 screening for useful substances such as anticancer agents; yeast PER1 gene
06/22/2010US7741086 Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
06/22/2010US7741083 Heat-treatment to produce glycolonitrile which is converted to ammonium glycolate using enzyme catalyst having nitrilase activity; low concentrations of impurities, high yield
06/22/2010US7741082 Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor
06/22/2010US7741081 comprises culturing in a medium an isolated microorganism carrying DNA encoding the modified N-acetylglutamate kinase ; efficiency
06/22/2010US7741080 elucidate the functional mechanism of adipocyte hypertrophy-dependent suppression of adiponectin production; identifies factors that can increase the expression of adiponectin gene; provides adiponectin expression-inducing agents; metabolic or heart diseases
06/22/2010US7741079 Method of making a genetically modified mammalian cell
06/22/2010US7741078 Heparin-binding protein modified with heparan sulfate sugar chains, process for producing the same and pharmaceutical compositions containing the same
06/22/2010US7741077 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
06/22/2010US7741076 developing genetic constructs capable of expressing lipidated rP6 in e coli; used for to preventing disease caused by Haemophilus influenzae
06/22/2010US7741075 Pichia pastoris PIR1 secretion signal peptide for recombinant protein expression and Pichia pastoris PIR1 and PIR2 anchor domain peptides for recombinant surface display
06/22/2010US7741074 Endoglucanases digest the cellulose polymer at random locations, opening it to attack by cellobiohydrolases which sequentially release molecules of cellobiose from the ends of the cellulose polymer
06/22/2010US7741073 Plastidial targeting peptide
06/22/2010US7741072 Polypeptide variants
06/22/2010US7741071 Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells
06/22/2010US7741070 Gene targets for enhanced carotenoid production
06/22/2010US7741064 biological reagents comprising the GPCR oligomers, methods of producing said biological reagents and assays for determining their function; determining compounds that have the ability to modulate the function of GPCR oligomers
06/22/2010US7741063 fusion protein that is antigenic and effective to elicit an immune response against Toxoplasma gondii oocysts
06/22/2010US7741057 Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
06/22/2010US7741056 Junctional Adhesion Molecule (JAM); treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer; antagonist of a native sequence STIgMA polypeptide
06/22/2010US7741055 prostate cancer and benign prostatic hyperplasia; promote tissue regeneration and to facilitate wound healing
06/22/2010US7741051 a fragment derived from the MET ectodomain in monomer form binds to hepatocyte growth factor/scatter factor (HGF/SF) either in the presence or absence of heparin; method for determining whether an agent binds to a MET ectodomain fragment in monomeric form
06/22/2010US7741049 Detection of receptor agonist; obtain sample containing receptor, incubate with modulator, monitor signal from receptor
06/22/2010US7741047 Using histone binding protein (RBAp48) as evaluative tool in identifying modulators for treatment of sjogren's syndrome
06/22/2010US7741044 dividing the support into lots, performing a different chemical reaction on each lot of the support, tagging a fraction of each lot of the support with a different label, and combining the said lots of the support; used in assays and nucleic acid analysis
06/22/2010US7741040 Methods and compositions for detecting cancers
06/22/2010US7741039 Postweaning multisystemic wasting syndrome virus from pigs
06/22/2010US7741036 by a combination of nucleic acid amplification and molecular weight determination using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent
06/22/2010US7741030 detecting whether CpG sequences in a region from base 374 to base 592 in a DR3 gene promoter region obtained from synovial cells or synovial infiltrating lymphocytes of the human subject are methylated or not
06/22/2010US7741027 Nucleic acid oligomers; protease, reverse transcriptase; labeled oligonucleotide that specifically hybridizes; determine appropriate treatment
06/22/2010US7741026 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs